ID

40047

Beskrivning

Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.; ODM derived from: https://clinicaltrials.gov/show/NCT01541189

Länk

https://clinicaltrials.gov/show/NCT01541189

Nyckelord

Versioner (1)
  1. 2020-03-10 2020-03-10 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

10 mars 2020

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Hypertension NCT01541189

Engelsk

Eligibility Hypertension NCT01541189

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
naive primary hypertension patients or primary hypertensive patients on mono antihypertensive therapy:
Beskrivning

Essential Hypertension | Therapy naive | Antihypertensive therapy

Datatyp

boolean

Alias
UMLS CUI [1]
C0085580
UMLS CUI [2]
C0919936
UMLS CUI [3]
C0585941
all treatment-naive patients need to have 140mmhg≤mssbp<180mmhg and 90mmhg≤msdbp< 110mmhg at visit 1
Beskrivning

Therapy naive | Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean

Datatyp

boolean

Alias
UMLS CUI [1]
C0919936
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C1319894
UMLS CUI [3,2]
C0444504
for patients on mono antihypertensive therapy, mssbp/msdbp should <160/100mmhg at visit 1 (the beginning of screening period); and at visit 2(the beginning of theraputic period), they should have mssbp≥140 mmhg and <180mmhg and msdbp≥90 mmhg and <110mmhg
Beskrivning

Antihypertensive therapy | Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean | Time Period Screening | Time Period Therapeutic

Datatyp

boolean

Alias
UMLS CUI [1]
C0585941
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C1319894
UMLS CUI [3,2]
C0444504
UMLS CUI [4,1]
C1948053
UMLS CUI [4,2]
C1710032
UMLS CUI [5,1]
C1948053
UMLS CUI [5,2]
C0302350
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
severe hypertension
Beskrivning

Hypertension, severe

Datatyp

boolean

Alias
UMLS CUI [1]
C4013784
malignant hypertension
Beskrivning

Malignant Hypertension

Datatyp

boolean

Alias
UMLS CUI [1]
C0020540
secondary hypertension
Beskrivning

Secondary hypertension

Datatyp

boolean

Alias
UMLS CUI [1]
C0155616
renal dysfunction(serum creatinine > 2.0mg(176.8μmol/l)at visit 1)
Beskrivning

Renal dysfunction | Creatinine measurement, serum

Datatyp

boolean

Alias
UMLS CUI [1]
C3279454
UMLS CUI [2]
C0201976
hepatic disease
Beskrivning

Liver disease

Datatyp

boolean

Alias
UMLS CUI [1]
C0023895
history of hypertensive encephalopathy or cerebrovascular accident within 6 months
Beskrivning

Hypertensive Encephalopathy | Cerebrovascular accident

Datatyp

boolean

Alias
UMLS CUI [1]
C0151620
UMLS CUI [2]
C0038454
history of myocardial infarction, coronary revascularization within 6 months
Beskrivning

Myocardial Infarction | Coronary revascularisation

Datatyp

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0877341
type 1 diabetes mellitus
Beskrivning

Diabetes Mellitus, Insulin-Dependent

Datatyp

boolean

Alias
UMLS CUI [1]
C0011854
patietns with hba1c >8% at visit 1
Beskrivning

Hemoglobin A1c measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0474680
women in pregnancy and lactation
Beskrivning

Pregnancy | Breast Feeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
potentially fertile female patients not using effective contraceptive methods
Beskrivning

Childbearing Potential Contraceptive methods Absent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0332197
be allergy to study drug.
Beskrivning

Hypersensitivity Investigational New Drugs

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
other protocol defined inclusion/exlusion criteria may apply
Beskrivning

Eligibility Criteria Study Protocol

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Tillbaka till toppen

Similar models

Eligibility Hypertension NCT01541189

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Essential Hypertension | Therapy naive | Antihypertensive therapy
Item
naive primary hypertension patients or primary hypertensive patients on mono antihypertensive therapy:
boolean
C0085580 (UMLS CUI [1])
C0919936 (UMLS CUI [2])
C0585941 (UMLS CUI [3])
Therapy naive | Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean
Item
all treatment-naive patients need to have 140mmhg≤mssbp<180mmhg and 90mmhg≤msdbp< 110mmhg at visit 1
boolean
C0919936 (UMLS CUI [1])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319894 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Antihypertensive therapy | Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean | Time Period Screening | Time Period Therapeutic
Item
for patients on mono antihypertensive therapy, mssbp/msdbp should <160/100mmhg at visit 1 (the beginning of screening period); and at visit 2(the beginning of theraputic period), they should have mssbp≥140 mmhg and <180mmhg and msdbp≥90 mmhg and <110mmhg
boolean
C0585941 (UMLS CUI [1])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319894 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
C1948053 (UMLS CUI [4,1])
C1710032 (UMLS CUI [4,2])
C1948053 (UMLS CUI [5,1])
C0302350 (UMLS CUI [5,2])
Item Group
C0680251 (UMLS CUI)
Hypertension, severe
Item
severe hypertension
boolean
C4013784 (UMLS CUI [1])
Malignant Hypertension
Item
malignant hypertension
boolean
C0020540 (UMLS CUI [1])
Secondary hypertension
Item
secondary hypertension
boolean
C0155616 (UMLS CUI [1])
Renal dysfunction | Creatinine measurement, serum
Item
renal dysfunction(serum creatinine > 2.0mg(176.8μmol/l)at visit 1)
boolean
C3279454 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Liver disease
Item
hepatic disease
boolean
C0023895 (UMLS CUI [1])
Hypertensive Encephalopathy | Cerebrovascular accident
Item
history of hypertensive encephalopathy or cerebrovascular accident within 6 months
boolean
C0151620 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
Myocardial Infarction | Coronary revascularisation
Item
history of myocardial infarction, coronary revascularization within 6 months
boolean
C0027051 (UMLS CUI [1])
C0877341 (UMLS CUI [2])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
patietns with hba1c >8% at visit 1
boolean
C0474680 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
women in pregnancy and lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Childbearing Potential Contraceptive methods Absent
Item
potentially fertile female patients not using effective contraceptive methods
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Hypersensitivity Investigational New Drugs
Item
be allergy to study drug.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Eligibility Criteria Study Protocol
Item
other protocol defined inclusion/exlusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial